Obrist R - Search Results

1

[Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)].

Gratwohl A, Dazzi H, Tichelli A, Stebler C, Wernli M, Thomssen C, Kim I, Dieterle A, Obrist R, Stern A, et al. Gratwohl A, et al. Among authors: obrist r. Schweiz Med Wochenschr. 1991 Mar 23;121(12):413-7. Schweiz Med Wochenschr. 1991. PMID: 2028244 German.

2

Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I tolerability study.

Dieterle A, Gratwohl A, Ritz R, Obrecht JP, Obrist R. Dieterle A, et al. Among authors: obrist r. Ann Oncol. 1991 Jan;2(1):69-70. doi: 10.1093/oxfordjournals.annonc.a057828. Ann Oncol. 1991. PMID: 2009237 Free article. Clinical Trial. No abstract available.

3

[Significance of hormone receptors in the therapy of breast cancer].

Obrist R, Obrecht JP. Obrist R, et al. Schweiz Med Wochenschr. 1983 May 21;113(20):749-53. Schweiz Med Wochenschr. 1983. PMID: 6879128 German.

4

Effectiveness and low toxicity of hepatic artery infusion with fluorouracil and mitomycin for metastatic colorectal cancer confined to the liver. The Swiss Group for Clinical and Epidemiological Cancer Research (SAKK).

Borner M, Laffer U, Ludwig C, Obrist R, Metzger U, Aeberhard P, Weber W, Castiglione M, Obrecht JP, Brunner K, et al. Borner M, et al. Among authors: obrist r. Ann Oncol. 1990;1(3):227-8. doi: 10.1093/oxfordjournals.annonc.a057726. Ann Oncol. 1990. PMID: 2261369 Free article.

5

Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trial.

Obrist R, Schmidli J, Müller R, Gallati H, Obrecht JP. Obrist R, et al. Cancer Immunol Immunother. 1991;32(6):406-8. doi: 10.1007/BF01741336. Cancer Immunol Immunother. 1991. PMID: 2007248 Free PMC article. Clinical Trial.

6

[Tumor patients and alternative medicine. Attempt at characterizing users of alternative treatment methods in oncology].

Berger DP, Obrist R, Obrecht JP. Berger DP, et al. Among authors: obrist r. Dtsch Med Wochenschr. 1989 Mar 3;114(9):323-30. doi: 10.1055/s-2008-1066596. Dtsch Med Wochenschr. 1989. PMID: 2920678 German.

7

[Cytokines in the clinic].

Obrist R. Obrist R. Helv Chir Acta. 1990 Jan;56(5):683-8. Helv Chir Acta. 1990. PMID: 2182570 Review. German.

8

Intraperitoneal chemotherapy in peritoneal malignancy: impact of intensive system care on practicability.

Knüsli C, Ruff P, Laffer U, Stoll HR, Obrist R, Weber W, Obrecht JP. Knüsli C, et al. Among authors: obrist r. Acta Med Austriaca. 1989;16(3-4):70-3. Acta Med Austriaca. 1989. PMID: 2692376

9

[10 years' therapy of Hodgkin's disease in the Oncology Department of the Basel Canton Hospital: a retrospective study].

Battegay M, Obrist R, Obrecht JP. Battegay M, et al. Among authors: obrist r. Onkologie. 1987 Oct;10(5):308-11. doi: 10.1159/000216430. Onkologie. 1987. PMID: 3317173 German. No abstract available.

10

[Immune profile in patients with Hodgkin's disease in long-term remission after cytostatic chemotherapy].

Nagel GA, Pietra CD, Hartmann D, Rosenthal M, Albrecht R, Obrist R, Obrecht P. Nagel GA, et al. Among authors: obrist r. Schweiz Med Wochenschr. 1979 Jan 13;109(2):45-51. Schweiz Med Wochenschr. 1979. PMID: 311514 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters